The United States has donated an experimental Ebola antibody treatment, MBP134, to Uganda to aid in its response to the current outbreak. The treatment, received by Uganda’s Ministry of Health, demonstrates promise in preventing fatalities among Ebola patients. Dr. Charles Ayume, Minister of State for Primary Health Care, accepted the donation on behalf of the Ugandan government. This donation signifies ongoing international collaboration in combating the deadly virus. Further details regarding the implementation and efficacy of MBP134 within Uganda’s treatment protocols are anticipated. The move aims to bolster Uganda’s resources and improve patient outcomes during this health crisis. This assistance reflects a commitment to supporting global health security.